Experience | Mintz

Co-lead trial counsel in the 2020 jury trial of a nationwide class action alleging global price fixing in sales of capacitors.
Lead U.S. antitrust counsel for Qiagen N.V. in its $11 billion sale to Thermo Fisher Scientific, announced in March 2020.
Successfully represented a global contract manufacturer before the Committee on Foreign Investment in the United States (CFIUS) in its 2020 acquisition by a Chinese investor.
Serves as ongoing antitrust counsel to one of the nation’s largest and most respected integrated physician/hospital provider network on matters including mergers, affiliations, investigations, and litigation.
Represented the nation’s premier retail pharmacy chain in its $27 billion industry-transforming acquisition of a “big three” pharmacy benefits manager.
Serves as ongoing antitrust counsel to several of the world’s leading genetic and molecular diagnostic test developers and providers.
Lead counsel for three separate cable operators in sprawling multidistrict litigation involving more than 30 separate suits filed around the country relating to the alleged tying of cable set-top boxes to certain cable services.
Serves as ongoing antitrust counsel to one of the world’s largest and most recognizable brands in healthcare equipment and technology.
Serves as ongoing antitrust, regulatory, and litigation counsel to several of the nation’s leading cable, media, and wireless telecommunications companies and trade associations.
Provides ongoing antitrust and foreign investment counsel to dozens of early-stage companies in biotech, healthcare, green energy, and high-tech manufacturing.

Mintz Advises Wavecrest Growth Partners on Acquisition of Dealerware

Mintz advised Wavecrest on its acquisition of Dealerware, enhancing growth in auto‑tech with a platform serving 60,000+ vehicles across nearly 2,000 dealerships.

Mintz Advises Philips on SpectraWAVE Acquisition

Mintz advised Royal Philips on its agreement to acquire SpectraWAVE, enhancing Philips’ intravascular imaging and AI-driven physiology solutions for coronary artery disease treatment.

Mintz Advises Seven Starling on $8M Series A-Prime Financing

Mintz advised Seven Starling, a virtual health provider specializing in mental health care during fertility, pregnancy, postpartum, and early parenthood, on its $8M Series A-Prime financing, led by Rethink Impact.

Mintz Advises PHLUR on Acquisition by TSG Consumer

Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.

Mintz Advises Muse Group on Combination with Hal Leonard and Growth Investment by Francisco Partners

Mintz represented Muse Group in its recent combination with Hal Leonard and growth investment by Francisco Partners. Learn how this combination creates a global music learning platform and more.

Mintz Represents JMP in Sale to Citizens Financial

Attorney Andrew Thorpe led a Mintz legal team that represented JMP Group LLC, a capital markets firm, in its sale to Citizens Financial Group.

Mintz Advises IDG in Its $1.3B Sale to Blackstone

Mintz represented International Data Group, Inc., a leading market intelligence and data platform for the technology industry, in its sale to private equity funds managed by Blackstone.

Team Resolves Investigation of HSR 2nd Request

Mintz led a heavily negotiated settlement that enabled a large health care system to acquire a hospital and physician group. The joint Department of Justice, state Attorney General, and state agency investigation included a “second request” in accordance with the Hart-Scott-Rodino (HSR) Act.

Team Resolves FTC Matter, Enables Fortune 50 Merger

Mintz guided a Fortune 50 corporation through a joint investigation by the Federal Trade Commission’s Bureau of Competition and Bureau of Consumer Protection that included civil investigative demands and hearings. The corporation’s merger was preserved, and none of its actions was challenged.

Defense Against Class Action, Cartel Allegations

Mintz is leading a NYSE company’s defense in US criminal price-fixing cartel investigations and a US class action with nearly two dozen codefendants. Mintz is also coordinating with non-US counsel on related foreign actions regarding the alleged international cartel.